-
1
-
-
0032882628
-
Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation
-
Alt M., Eisenhardt S., Serwe M., Renz R., Engels J.W., Caselmann W.H. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation. Eur. J. Clin. Invest. 1999, 29:868-876.
-
(1999)
Eur. J. Clin. Invest.
, vol.29
, pp. 868-876
-
-
Alt, M.1
Eisenhardt, S.2
Serwe, M.3
Renz, R.4
Engels, J.W.5
Caselmann, W.H.6
-
2
-
-
0029156656
-
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides
-
Alt M., Renz R., Hofschneider P.H., Paumgartner G., Caselmann W.H. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 1995, 22:707-717.
-
(1995)
Hepatology
, vol.22
, pp. 707-717
-
-
Alt, M.1
Renz, R.2
Hofschneider, P.H.3
Paumgartner, G.4
Caselmann, W.H.5
-
3
-
-
84857683435
-
Current status and future directions in the management of chronic hepatitis C
-
Aman W., Mousa S., Shiha G., Mousa S.A. Current status and future directions in the management of chronic hepatitis C. Virol. J. 2012, 2:9-57.
-
(2012)
Virol. J.
, vol.2
, pp. 9-57
-
-
Aman, W.1
Mousa, S.2
Shiha, G.3
Mousa, S.A.4
-
4
-
-
33748956796
-
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
-
Barbara C., Orlandi P., Bocci G., Fioravanti A., Di Paolo A., Natale G., Del Tacca M., Danesi R. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma. Eur. J. Pharmacol. 2006, 549:24-34.
-
(2006)
Eur. J. Pharmacol.
, vol.549
, pp. 24-34
-
-
Barbara, C.1
Orlandi, P.2
Bocci, G.3
Fioravanti, A.4
Di Paolo, A.5
Natale, G.6
Del Tacca, M.7
Danesi, R.8
-
5
-
-
0036211864
-
Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells
-
Briz O., Serrano M.A., Rebollo N., Hagenbuch B., Meier P.J., Koepsell H., Marin J.J. Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells. Mol. Pharmacol. 2002, 61:853-860.
-
(2002)
Mol. Pharmacol.
, vol.61
, pp. 853-860
-
-
Briz, O.1
Serrano, M.A.2
Rebollo, N.3
Hagenbuch, B.4
Meier, P.J.5
Koepsell, H.6
Marin, J.J.7
-
6
-
-
0026728652
-
Sequence analysis of the 5' noncoding region of hepatitis C virus
-
Bukh J., Purcell R.H., Miller R.H. Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4942-4946.
-
(1992)
Proc. Natl. Acad. Sci. U.S.A.
, vol.89
, pp. 4942-4946
-
-
Bukh, J.1
Purcell, R.H.2
Miller, R.H.3
-
7
-
-
77955717450
-
Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs
-
Chang B., Lee C.H., Lee J.H., Lee S.W. Comparative analysis of intracellular inhibition of hepatitis C virus replication by small interfering RNAs. Biotechnol. Lett. 2010, 32:1231-1237.
-
(2010)
Biotechnol. Lett.
, vol.32
, pp. 1231-1237
-
-
Chang, B.1
Lee, C.H.2
Lee, J.H.3
Lee, S.W.4
-
8
-
-
0025968921
-
Genetic organization and diversity of the hepatitis C virus
-
Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P.J., et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2451-2455.
-
(1991)
Proc. Natl. Acad. Sci. U.S.A.
, vol.88
, pp. 2451-2455
-
-
Choo, Q.L.1
Richman, K.H.2
Han, J.H.3
Berger, K.4
Lee, C.5
Dong, C.6
Gallegos, C.7
Coit, D.8
Medina-Selby, R.9
Barr, P.J.10
-
9
-
-
0345700691
-
Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma
-
Cui Y., Konig J., Nies A.T., Pfannschmidt M., Hergt M., Franke W.W., Alt W., Moll R., Keppler D. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab. Invest. 2003, 83:527-538.
-
(2003)
Lab. Invest.
, vol.83
, pp. 527-538
-
-
Cui, Y.1
Konig, J.2
Nies, A.T.3
Pfannschmidt, M.4
Hergt, M.5
Franke, W.W.6
Alt, W.7
Moll, R.8
Keppler, D.9
-
10
-
-
69549097534
-
Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties
-
De Rosa G., La Rotonda M.I. Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties. Molecules 2009, 14:2801-2823.
-
(2009)
Molecules
, vol.14
, pp. 2801-2823
-
-
De Rosa, G.1
La Rotonda, M.I.2
-
11
-
-
63749120634
-
Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes
-
Delogu L.G., Magrini A., Bergamaschi A., Rosato N., Dawson M.I., Bottini N., Bottini M. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug. Chem. 2009, 20:427-431.
-
(2009)
Bioconjug. Chem.
, vol.20
, pp. 427-431
-
-
Delogu, L.G.1
Magrini, A.2
Bergamaschi, A.3
Rosato, N.4
Dawson, M.I.5
Bottini, N.6
Bottini, M.7
-
12
-
-
0030024402
-
Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors
-
Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., Van Der Eb A.J. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 1996, 7:215-222.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 215-222
-
-
Fallaux, F.J.1
Kranenburg, O.2
Cramer, S.J.3
Houweling, A.4
Van Ormondt, H.5
Hoeben, R.C.6
Van Der Eb, A.J.7
-
13
-
-
0037347125
-
Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression
-
Fukuma T., Walton C.M., Wu C.H., Wu G.Y. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression. Bioconjug. Chem. 2003, 14:295-301.
-
(2003)
Bioconjug. Chem.
, vol.14
, pp. 295-301
-
-
Fukuma, T.1
Walton, C.M.2
Wu, C.H.3
Wu, G.Y.4
-
14
-
-
33646164388
-
Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells
-
Gonzalez-Carmona M.A., Schussler S., Serwe M., Alt M., Ludwig J., Sproat B.S., Steigerwald R., Hoffmann P., Quasdorff M., Schildgen O., Caselmann W.H. Hammerhead ribozymes with cleavage site specificity for NUH and NCH display significant anti-hepatitis C viral effect in vitro and in recombinant HepG2 and CCL13 cells. J. Hepatol. 2006, 44:1017-1025.
-
(2006)
J. Hepatol.
, vol.44
, pp. 1017-1025
-
-
Gonzalez-Carmona, M.A.1
Schussler, S.2
Serwe, M.3
Alt, M.4
Ludwig, J.5
Sproat, B.S.6
Steigerwald, R.7
Hoffmann, P.8
Quasdorff, M.9
Schildgen, O.10
Caselmann, W.H.11
-
15
-
-
79958773820
-
Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo
-
Gonzalez-Carmona M.A., Vogt A., Heinicke T., Quasdorff M., Hoffmann P., Yildiz Y., Schneider C., Serwe M., Bartenschlager R., Sauerbruch T., Caselmann W.H. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo. J. Hepatol. 2011, 55:19-28.
-
(2011)
J. Hepatol.
, vol.55
, pp. 19-28
-
-
Gonzalez-Carmona, M.A.1
Vogt, A.2
Heinicke, T.3
Quasdorff, M.4
Hoffmann, P.5
Yildiz, Y.6
Schneider, C.7
Serwe, M.8
Bartenschlager, R.9
Sauerbruch, T.10
Caselmann, W.H.11
-
16
-
-
36749000460
-
Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates
-
Guerniou V., Gillet R., Berree F., Carboni B., Felden B. Targeted inhibition of the hepatitis C internal ribosomal entry site genomic RNA with oligonucleotide conjugates. Nucleic Acids Res. 2007, 35:6778-6787.
-
(2007)
Nucleic Acids Res.
, vol.35
, pp. 6778-6787
-
-
Guerniou, V.1
Gillet, R.2
Berree, F.3
Carboni, B.4
Felden, B.5
-
17
-
-
0029893370
-
Sinusoidal (basolateral) bile salt uptake systems of hepatocytes
-
Hagenbuch B., Meier P.J. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin. Liver Dis. 1996, 16:129-136.
-
(1996)
Semin. Liver Dis.
, vol.16
, pp. 129-136
-
-
Hagenbuch, B.1
Meier, P.J.2
-
18
-
-
0032478271
-
A simplified system for generating recombinant adenoviruses
-
He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 1998, 95:2509-2514.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 2509-2514
-
-
He, T.C.1
Zhou, S.2
da Costa, L.T.3
Yu, J.4
Kinzler, K.W.5
Vogelstein, B.6
-
19
-
-
0035214935
-
Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor
-
Heintges T., Encke J., zu Putlitz J., Wands J.R. Inhibition of hepatitis C virus NS3 function by antisense oligodeoxynucleotides and protease inhibitor. J. Med. Virol. 2001, 65:671-680.
-
(2001)
J. Med. Virol.
, vol.65
, pp. 671-680
-
-
Heintges, T.1
Encke, J.2
zu Putlitz, J.3
Wands, J.R.4
-
20
-
-
0026920673
-
Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells
-
Iversen P.L., Zhu S., Meyer A., Zon G. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 1992, 2:211-222.
-
(1992)
Antisense Res. Dev.
, vol.2
, pp. 211-222
-
-
Iversen, P.L.1
Zhu, S.2
Meyer, A.3
Zon, G.4
-
21
-
-
0030910379
-
Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity
-
Kagedahl M., Swaan P.W., Redemann C.T., Tang M., Craik C.S., Szoka F.C., Oie S. Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity. Pharm. Res. 1997, 14:176-180.
-
(1997)
Pharm. Res.
, vol.14
, pp. 176-180
-
-
Kagedahl, M.1
Swaan, P.W.2
Redemann, C.T.3
Tang, M.4
Craik, C.S.5
Szoka, F.C.6
Oie, S.7
-
22
-
-
0242469240
-
Organic anion-transporting polypeptide (OATP) transporter family and drug disposition
-
Kim R.B. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur. J. Clin. Invest. 2003, 33:1-5.
-
(2003)
Eur. J. Clin. Invest.
, vol.33
, pp. 1-5
-
-
Kim, R.B.1
-
23
-
-
0037733365
-
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
-
Konig J., Cui Y., Nies A.T., Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G156-G164.
-
(2000)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.278
-
-
Konig, J.1
Cui, Y.2
Nies, A.T.3
Keppler, D.4
-
24
-
-
0029822826
-
Bile acid transport systems as pharmaceutical targets
-
Kramer W., Wess G. Bile acid transport systems as pharmaceutical targets. Eur. J. Clin. Invest. 1996, 26:715-732.
-
(1996)
Eur. J. Clin. Invest.
, vol.26
, pp. 715-732
-
-
Kramer, W.1
Wess, G.2
-
25
-
-
0029870313
-
Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells
-
Kullak-Ublick G.A., Beuers U., Paumgartner G. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology 1996, 23:1053-1560.
-
(1996)
Hepatology
, vol.23
, pp. 1053-1560
-
-
Kullak-Ublick, G.A.1
Beuers, U.2
Paumgartner, G.3
-
26
-
-
0030838171
-
Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas
-
Kullak-Ublick G.A., Glasa J., Boker C., Oswald M., Grutzner U., Hagenbuch B., Stieger B., Meier P.J., Beuers U., Kramer W., Wess G., Paumgartner G. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 1997, 113:1295-1305.
-
(1997)
Gastroenterology
, vol.113
, pp. 1295-1305
-
-
Kullak-Ublick, G.A.1
Glasa, J.2
Boker, C.3
Oswald, M.4
Grutzner, U.5
Hagenbuch, B.6
Stieger, B.7
Meier, P.J.8
Beuers, U.9
Kramer, W.10
Wess, G.11
Paumgartner, G.12
-
27
-
-
0035125407
-
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
-
Kullak-Ublick G.A., Ismair M.G., Stieger B., Landmann L., Huber R., Pizzagalli F., Fattinger K., Meier P.J., Hagenbuch B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001, 120:525-533.
-
(2001)
Gastroenterology
, vol.120
, pp. 525-533
-
-
Kullak-Ublick, G.A.1
Ismair, M.G.2
Stieger, B.3
Landmann, L.4
Huber, R.5
Pizzagalli, F.6
Fattinger, K.7
Meier, P.J.8
Hagenbuch, B.9
-
28
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., Persson R., Lindow M., Munk M.E., Kauppinen S., Orum H. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
-
(2010)
Science
, vol.327
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
Persson, R.4
Lindow, M.5
Munk, M.E.6
Kauppinen, S.7
Orum, H.8
-
29
-
-
0034944358
-
Synthesis and properties of bile acid phosphoramidites 5'-tethered to antisense oligodeoxynucleotides against HCV
-
Lehmann T.J., Engels J.W. Synthesis and properties of bile acid phosphoramidites 5'-tethered to antisense oligodeoxynucleotides against HCV. Bioorg. Med. Chem. 2001, 9:1827-1835.
-
(2001)
Bioorg. Med. Chem.
, vol.9
, pp. 1827-1835
-
-
Lehmann, T.J.1
Engels, J.W.2
-
30
-
-
0034851905
-
Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting
-
Lehmann T.J., Serwe M., Caselmann W.H., Engels J.W. Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting. Nucleosides, Nucleotides Nucleic Acids 2001, 20:1343-1346.
-
(2001)
Nucleosides, Nucleotides Nucleic Acids
, vol.20
, pp. 1343-1346
-
-
Lehmann, T.J.1
Serwe, M.2
Caselmann, W.H.3
Engels, J.W.4
-
31
-
-
0142039147
-
Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides
-
Lischka K., Starke D., Failing K., Herling A., Kramer W., Petzinger E. Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats: evidence for mrp2 as carrier for oligodeoxynucleotides. Biochem. Pharmacol. 2003, 66:565-577.
-
(2003)
Biochem. Pharmacol.
, vol.66
, pp. 565-577
-
-
Lischka, K.1
Starke, D.2
Failing, K.3
Herling, A.4
Kramer, W.5
Petzinger, E.6
-
32
-
-
0345188811
-
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
-
Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285:110-113.
-
(1999)
Science
, vol.285
, pp. 110-113
-
-
Lohmann, V.1
Korner, F.2
Koch, J.3
Herian, U.4
Theilmann, L.5
Bartenschlager, R.6
-
33
-
-
79955692689
-
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
-
Lupberger J., Zeisel M.B., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C.j., Turek M., Gorke S., Royer C., Fischer B., Zahid M.N., Lavillette D., Fresquet J., Cosset F.L., Rothenberg S.M., Pietschmann T., Patel A.H., Pessaux P., Doffoel M., Raffelsberger W., Poch O., McKeating J.A., Brino L., Baumert T.F. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17:589-595.
-
(2011)
Nat. Med.
, vol.17
, pp. 589-595
-
-
Lupberger, J.1
Zeisel, M.B.2
Xiao, F.3
Thumann, C.4
Fofana, I.5
Zona, L.6
Davis, C.7
Mee, C.8
Turek, M.9
Gorke, S.10
Royer, C.11
Fischer, B.12
Zahid, M.N.13
Lavillette, D.14
Fresquet, J.15
Cosset, F.L.16
Rothenberg, S.M.17
Pietschmann, T.18
Patel, A.H.19
Pessaux, P.20
Doffoel, M.21
Raffelsberger, W.22
Poch, O.23
McKeating, J.A.24
Brino, L.25
Baumert, T.F.26
more..
-
34
-
-
0036788338
-
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
-
McHutchison J.G., Manns M., Patel K., Poynard T., Lindsay K.L., Trepo C., Dienstag J., Lee W.M., Mak C., Garaud J.J., Albrecht J.K. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002, 123:1061-1069.
-
(2002)
Gastroenterology
, vol.123
, pp. 1061-1069
-
-
McHutchison, J.G.1
Manns, M.2
Patel, K.3
Poynard, T.4
Lindsay, K.L.5
Trepo, C.6
Dienstag, J.7
Lee, W.M.8
Mak, C.9
Garaud, J.J.10
Albrecht, J.K.11
-
35
-
-
28844476544
-
A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients
-
McHutchison J.G., Patel K., Pockros P., Nyberg L., Pianko S., Yu R.Z., Dorr F.A., Kwoh T.J. A phase I trial of an antisense inhibitor of hepatitis C virus (ISIS 14803), administered to chronic hepatitis C patients. J. Hepatol. 2006, 44:88-96.
-
(2006)
J. Hepatol.
, vol.44
, pp. 88-96
-
-
McHutchison, J.G.1
Patel, K.2
Pockros, P.3
Nyberg, L.4
Pianko, S.5
Yu, R.Z.6
Dorr, F.A.7
Kwoh, T.J.8
-
36
-
-
84855219215
-
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
-
Mitchell L.S., Rafael E. Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?. Liver Int. 2012, 32:54-60.
-
(2012)
Liver Int.
, vol.32
, pp. 54-60
-
-
Mitchell, L.S.1
Rafael, E.2
-
38
-
-
67649295505
-
SiRNA delivery systems for cancer treatment
-
Oh Y.K., Park T.G. SiRNA delivery systems for cancer treatment. Adv. Drug Deliv. Rev. 2009, 61:850-862.
-
(2009)
Adv. Drug Deliv. Rev.
, vol.61
, pp. 850-862
-
-
Oh, Y.K.1
Park, T.G.2
-
39
-
-
0032737711
-
Hepatobiliary transport of bile acid amino acid, bile acid peptide, and bile acid oligonucleotide conjugates in rats
-
Petzinger E., Wickboldt A., Pagels P., Starke D., Kramer W. Hepatobiliary transport of bile acid amino acid, bile acid peptide, and bile acid oligonucleotide conjugates in rats. Hepatology 1999, 30:1257-1268.
-
(1999)
Hepatology
, vol.30
, pp. 1257-1268
-
-
Petzinger, E.1
Wickboldt, A.2
Pagels, P.3
Starke, D.4
Kramer, W.5
-
40
-
-
33751054761
-
Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists
-
Richards S.J., von Geldern T.W., Jacobson P., Wilcox D., Nguyen P., Ohman L., Osterlund M., Gelius B., Grynfarb M., Goos-Nilsson A., Wang J., Fung S., Kalmanovich M. Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists. Bioorg. Med. Chem. Lett. 2006, 16:6086-6090.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 6086-6090
-
-
Richards, S.J.1
von Geldern, T.W.2
Jacobson, P.3
Wilcox, D.4
Nguyen, P.5
Ohman, L.6
Osterlund, M.7
Gelius, B.8
Grynfarb, M.9
Goos-Nilsson, A.10
Wang, J.11
Fung, S.12
Kalmanovich, M.13
-
41
-
-
34247594930
-
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir
-
Sarrazin C., Kieffer T.L., Bartels D., Hanzelka B., Müh U., Welker M., Wincheringer D., Zhou Y., Chu H.M., Lin C., Weegink C., Reesink H., Zeuzem S., Kwong A.D. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 2007, 132:1767-1777.
-
(2007)
Gastroenterology
, vol.132
, pp. 1767-1777
-
-
Sarrazin, C.1
Kieffer, T.L.2
Bartels, D.3
Hanzelka, B.4
Müh, U.5
Welker, M.6
Wincheringer, D.7
Zhou, Y.8
Chu, H.M.9
Lin, C.10
Weegink, C.11
Reesink, H.12
Zeuzem, S.13
Kwong, A.D.14
-
42
-
-
0142091755
-
Inhibition of hepatitis C virus protein expression by RNA interference
-
Sen A., Steele R., Ghosh A.K., Basu A., Ray R., Ray R.B. Inhibition of hepatitis C virus protein expression by RNA interference. Virus Res. 2003, 96:27-35.
-
(2003)
Virus Res.
, vol.96
, pp. 27-35
-
-
Sen, A.1
Steele, R.2
Ghosh, A.K.3
Basu, A.4
Ray, R.5
Ray, R.B.6
-
43
-
-
0028905430
-
Variability of hepatitis C virus
-
Simmonds P. Variability of hepatitis C virus. Hepatology 1995, 21:570-583.
-
(1995)
Hepatology
, vol.21
, pp. 570-583
-
-
Simmonds, P.1
-
45
-
-
45749120326
-
Cell-penetrating peptides as delivery vehicles for biology and medicine
-
Stewart K.M., Horton K.L., Kelley S.O. Cell-penetrating peptides as delivery vehicles for biology and medicine. Org. Biomol. Chem. 2008, 6:2242-2255.
-
(2008)
Org. Biomol. Chem.
, vol.6
, pp. 2242-2255
-
-
Stewart, K.M.1
Horton, K.L.2
Kelley, S.O.3
-
46
-
-
0031193858
-
Enhanced transepithelial transport of peptides by conjugation to cholic acid
-
Swaan P.W., Hillgren K.M., Szoka F.C., Oie S. Enhanced transepithelial transport of peptides by conjugation to cholic acid. Bioconjug. Chem. 1997, 8:520-525.
-
(1997)
Bioconjug. Chem.
, vol.8
, pp. 520-525
-
-
Swaan, P.W.1
Hillgren, K.M.2
Szoka, F.C.3
Oie, S.4
-
47
-
-
73149113353
-
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
-
Susser S., Welsch C., Wang Y., Zettler M., Domingues F.S., Karey U., Hughes E., Ralston R., Tong X., Herrmann E., Zeuzem S., Sarrazin C. Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients. Hepatology 2009, 50:1709-1718.
-
(2009)
Hepatology
, vol.50
, pp. 1709-1718
-
-
Susser, S.1
Welsch, C.2
Wang, Y.3
Zettler, M.4
Domingues, F.S.5
Karey, U.6
Hughes, E.7
Ralston, R.8
Tong, X.9
Herrmann, E.10
Zeuzem, S.11
Sarrazin, C.12
-
48
-
-
0034709561
-
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family
-
Tamai I., Nezu J., Uchino H., Sai Y., Oku A., Shimane M., Tsuji A. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem. Biophys. Res. Commun. 2000, 273:251-260.
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.273
, pp. 251-260
-
-
Tamai, I.1
Nezu, J.2
Uchino, H.3
Sai, Y.4
Oku, A.5
Shimane, M.6
Tsuji, A.7
-
49
-
-
0037379362
-
Bile salt transporters: molecular characterization, function, and regulation
-
Trauner M., Boyer J.L. Bile salt transporters: molecular characterization, function, and regulation. Physiol. Rev. 2003, 83:633-671.
-
(2003)
Physiol. Rev.
, vol.83
, pp. 633-671
-
-
Trauner, M.1
Boyer, J.L.2
-
50
-
-
4544232586
-
Increased acyclovir oral bioavailability via a bile acid conjugate
-
Tolle-Sander S., Lentz K.A., Maeda D.Y., Coop A., Polli J.E. Increased acyclovir oral bioavailability via a bile acid conjugate. Mol. Pharm. 2004, 12:40-48.
-
(2004)
Mol. Pharm.
, vol.12
, pp. 40-48
-
-
Tolle-Sander, S.1
Lentz, K.A.2
Maeda, D.Y.3
Coop, A.4
Polli, J.E.5
-
51
-
-
0032922742
-
Antisense RNA gene therapy for studying and modulating biological processes
-
Weiss B., Davidkova G., Zhou L.W. Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. 1999, 55:334-358.
-
(1999)
Cell. Mol. Life Sci.
, vol.55
, pp. 334-358
-
-
Weiss, B.1
Davidkova, G.2
Zhou, L.W.3
|